CVS Stock Analysis: Buy, Sell, or Hold?
CVS - CVS HEALTH CORPORATION
$74.52
0.08 (0.11%)
▲
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 10, 2026
9d
Get Alerted When CVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
6 traders called CVS this week
86% bullish • 1 bearish
86% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CVS is down 10.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CVS is down 10.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$104.48
Based on 5.8% avg growth
INTRINSIC VALUE TODAY
$64.87
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CVS is currently trading at $74.52, which is considered oversold relative to its 30-day fair value range of $76.66 to $82.06. The stock's valuation (Forward PE: 10.4) is in line with its historical norms (11.0). Remarkably, the market is currently pricing in an annual earnings decline of 1.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CVS is in a uptrend. Immediate support is located at $70.69, while resistance sits at $84.00.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $94.76 (+27.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CVS is in a uptrend. Immediate support is located at $70.69, while resistance sits at $84.00.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $94.76 (+27.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$76.66 -
$82.06
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding CVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.3% below Wall St target ($94.76)
- WARNING: Recommendation downgraded due to -10.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$76.66 -
$82.06
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$70.69
Resistance Level
$84.00
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
10.39
Wall Street Target
$94.76
(+27.3%)
Revenue Growth (YoY)
7.8%
Earnings Growth (YoY)
-43.2%
Profit Margin
0.1%
Valuation Discount vs History
-1.9% cheaper
PE vs Historical
10.4 vs 11.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.9%
(market-implied from PE analysis)
1-Year Target
$73.03
(-2%)
2-Year Target
$71.64
(-4%)
3-Year Target
$70.28
(-6%)
3-Yr Target (if PE normalizes)
(PE: 10→11)
$74.43
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 7.6%)
$199.25
(+168%)
Base:
(SPY PE: 10.4, Growth: 7.6%)
$92.80
(+25%)
Bear:
(PE: 8.8, Growth: 7.6%)
$78.88
(+6%)
📈
Valuation based on Current Earnings
Forward PE: 10.05 | Forward EPS (Implied): $7.41
Bull Case
$89.98
(+21%)
Analyst growth 15.0%, PE expands to 10.6
Base Case
$74.52
(0%)
Market implied 0.0%, PE stable at 10.1
Bear Case
$57.01
(-24%)
Severe decline -15.0%, PE contracts to 9.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.4 to 11.0
Stabilization Target:
$78.84
(+5.9%)
PE Expansion Potential:
+5.9%
Last updated: January 30, 2026 7:49 PM ET
Data refreshes hourly during market hours. Next update: 8:49 PM
Data refreshes hourly during market hours. Next update: 8:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Val T. Hoyle
SELL
2025-09-23
Michael T. McCaul
SELL
2025-08-22
Anne A Finucane
SELL
7500 shares
2025-08-20
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$327 | 58 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$394 | 47 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$395 | 53 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$288 | 62 BUY |
|
CNC
Centene Corp |
BUY
19 analysts |
$44 | 53 HOLD |
Advanced CVS Option Strategies
Professional options setups generated by AI based on today's CVS price and gamma walls.
